DAVE vs. SRPT
Compare and contrast key facts about Dave Inc. (DAVE) and Sarepta Therapeutics, Inc. (SRPT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DAVE or SRPT.
Correlation
The correlation between DAVE and SRPT is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DAVE vs. SRPT - Performance Comparison
Key characteristics
DAVE:
1.45
SRPT:
-0.84
DAVE:
2.34
SRPT:
-1.25
DAVE:
1.29
SRPT:
0.82
DAVE:
1.42
SRPT:
-0.71
DAVE:
5.56
SRPT:
-1.65
DAVE:
23.90%
SRPT:
31.22%
DAVE:
92.14%
SRPT:
61.44%
DAVE:
-99.01%
SRPT:
-98.17%
DAVE:
-77.11%
SRPT:
-64.38%
Fundamentals
DAVE:
$1.40B
SRPT:
$6.24B
DAVE:
$4.19
SRPT:
$2.34
DAVE:
24.99
SRPT:
27.14
DAVE:
4.03
SRPT:
3.28
DAVE:
7.63
SRPT:
4.08
DAVE:
$273.45M
SRPT:
$1.49B
DAVE:
$226.28M
SRPT:
$1.21B
DAVE:
$33.69M
SRPT:
$251.31M
Returns By Period
In the year-to-date period, DAVE achieves a 20.51% return, which is significantly higher than SRPT's -47.64% return.
DAVE
20.51%
47.95%
178.07%
132.06%
N/A
N/A
SRPT
-47.64%
16.96%
-48.27%
-52.37%
-12.33%
15.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DAVE vs. SRPT — Risk-Adjusted Performance Rank
DAVE
SRPT
DAVE vs. SRPT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dave Inc. (DAVE) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DAVE vs. SRPT - Dividend Comparison
Neither DAVE nor SRPT has paid dividends to shareholders.
Drawdowns
DAVE vs. SRPT - Drawdown Comparison
The maximum DAVE drawdown since its inception was -99.01%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for DAVE and SRPT. For additional features, visit the drawdowns tool.
Volatility
DAVE vs. SRPT - Volatility Comparison
Dave Inc. (DAVE) has a higher volatility of 25.31% compared to Sarepta Therapeutics, Inc. (SRPT) at 22.68%. This indicates that DAVE's price experiences larger fluctuations and is considered to be riskier than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DAVE vs. SRPT - Financials Comparison
This section allows you to compare key financial metrics between Dave Inc. and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DAVE vs. SRPT - Profitability Comparison
DAVE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Dave Inc. reported a gross profit of 94.56M and revenue of 100.84M. Therefore, the gross margin over that period was 93.8%.
SRPT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported a gross profit of 526.11M and revenue of 658.41M. Therefore, the gross margin over that period was 79.9%.
DAVE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Dave Inc. reported an operating income of 20.99M and revenue of 100.84M, resulting in an operating margin of 20.8%.
SRPT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported an operating income of 161.68M and revenue of 658.41M, resulting in an operating margin of 24.6%.
DAVE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Dave Inc. reported a net income of 16.81M and revenue of 100.84M, resulting in a net margin of 16.7%.
SRPT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported a net income of 159.05M and revenue of 658.41M, resulting in a net margin of 24.2%.